Rhinoplasty.
Conditions
Interventions
Intervention 1: Intervention group: The test drug used for treatment in this study was a tea-bag formulation of tea plant leaves powder. Each teabag contained 2.5g of the leaves powder. The dose given
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing rhinoplasty
Exclusion criteria
Exclusion criteria: Use topical or oral medication to reduce edema and ecchymosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in pre-orbital ecchymosis are measured based on a score of 0-4. Timepoint: During the week after the operation, daily at a specific time. Method of measurement: Based on score of 0_4 , zero: no ecchymosis, 1: involvement in the medial canthus and less than 1/4, 2: involvement to the pupil and between 1/4 to 1/2, 3: Involvement over the pupil and between 1/2 to 3/4, 4: Involvement reaches the lateral canthus.;Eyelid edema changes based on a score of 0 to 4. Timepoint: During the week after the operation, daily at a specific time. Method of measurement: Based on a score of 0_4, zero: no edema, 1: involvement of a small amount of iris from above and below, 2: part of the iris is covered but does not reach the pupil 3: edema reaches the pupil and the iris is covered from above and below, 4 : The eyes are completely closed. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPegah Foroughi Mobarakeh
Iran University of Medical Sciences
Outcome results
None listed